Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
CalumetCLMT +4.33%52 3-Year EBITDA Growth Rate is 27.80% as of Jun. 2026. GuruFocus rates CLMT with a GF Score™ of 52/100 and a GF Value™ of $18.34 (Significantly Overvalued). The stock has 10 warning signs investors should review. Among 1,409 Chemicals companies, Calumet ranks better than 87.15% on this metric.
During the past 3 years, the average EBITDA Per Share Growth Rate was 27.80% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Calumet was 126.50% per year. The lowest was -96.20% per year. And the median was -2.00% per year.
EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.
Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.
Calumet 3-Year EBITDA Growth Rate Related Terms
CLMT vs AVNT, WDFC, ASH: 3-Year EBITDA Growth Rate Comparison
For the Specialty Chemicals subindustry, Calumet's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Calumet 3-Year EBITDA Growth Rate vs Chemicals Industry
For the Chemicals industry and Basic Materials sector, Calumet's 3-Year EBITDA Growth Rate distribution charts can be found below:
* The bar in red indicates where Calumet's 3-Year EBITDA Growth Rate falls into.
This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.
What does a 3-Year EBITDA Growth Rate of 27.80% mean?
Calumet (CLMT) has a 3-Year EBITDA Growth Rate of 27.80% as of Jun. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Calumet and its competitors. According to the industry distribution chart, Calumet ranks #181 out of 1409 companies in the Chemicals industry, placing it in the top 12.8%.
Is Calumet's 3-Year EBITDA Growth Rate too high?
Calumet's current 3-Year EBITDA Growth Rate is 27.80%. The Chemicals industry median 3-Year EBITDA Growth Rate is 0.80. Calumet's value of 27.80% is 3375% above this industry median. Based on the distribution chart, Calumet ranks #181 out of 1409 companies in the Chemicals industry, which is in the top quartile — a strong position relative to peers. Overall, Calumet has a GF Score™ of 52/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Calumet's 3-Year EBITDA Growth Rate compare to AVNT and WDFC?
According to the Chemicals industry distribution chart, Calumet ranks #181 out of 1409 companies for 3-Year EBITDA Growth Rate. This places Calumet in the top 13% of its industry — outperforming the majority of peers. The industry median 3-Year EBITDA Growth Rate is 0.80. Calumet's value of 27.80% is 3375% above this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.80, based on 1,409 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Calumet's current 3-Year EBITDA Growth Rate of 27.80% is 3375% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Calumet and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Calumet's current 3-Year EBITDA Growth Rate is 27.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Calumet stock overvalued right now?
Based on GuruFocus' analysis, Calumet (CLMT) is currently considered Significantly Overvalued. The stock's GF Value™ is $18.34, compared to a current price of $47.76 — trading 160.4% above its estimated fair value. The current 3-Year EBITDA Growth Rate is 27.80% and 3375% above the Chemicals industry median of 0.80. Calumet's overall GF Score™ is 52/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Calumet (CLMT), the current 3-Year EBITDA Growth Rate is 27.80% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Calumet (CLMT) Overvalued in 2026?
Based on GuruFocus' analysis, Calumet stock appears to be overvalued.
The current stock price of $47.76 is trading 160.4% above its estimated GF Value™ of $18.34.
GuruFocus considers Calumet to be Significantly Overvalued.
Key valuation signals for CLMT:
3-Year EBITDA Growth Rate: 27.80%
GF Value™: $18.34 vs. price of $47.76 (160.4% above fair value)
Industry Position: 3375% above the Chemicals median (#181 of 1409)
No single metric tells the full story. See the CLMT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Calumet Inc is a producer of specialty products, including base oils, specialty oils, solvents, esters, and waxes, as well as a variety of fuel and fuel-related products, including asphalt and heavy fuel oils. The company manufactures, formulates, and markets a variety of specialty branded products to customers in various consumer-facing and industrial markets. Its segments include: Specialty Products and Solutions; Montana/Renewables; Performance Brands; and Corporate. The company generates maximum revenue from Fuels, asphalt and other by-products.
52GF Score
Get the complete analysis for CLMT
3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
CLMT has been successfully added to your 
